(marketscreener.com) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or Section 15 of the Securities Exchange Act of 1934 Date of Report :...https://www.marketscreener.com/quote/stock/BIODELIVERY-SCIENCES-INTE-8541/news/BioDelivery-Sciences-International-Material-Definitive-Agreement-Form-8-K-A-39481972/?utm_medium=RSS&utm_content=20220215
BDSI is a North Carolina-based pharmaceutical company that develops and commercializes novel therapies for the treatment of debilitating chronic conditions.